Clinical Trials Directory

Trials / Completed

CompletedNCT00803517

Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy

Comparison of Multifocal Electroretinogram Assessment Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.

Detailed description

1. Laser Group: extrafoveal focal leakage on FAG 2. PDT Group: no definite focal leak on FAG subfoveal or juxtafoveal focal leakage on FAG, or serous retinal pigmentary epithelial detachment involving foveal center Inclusion criteria 1. Chronic serous chorioretinopathy (over 3 months) when subretinal fluid persisted in the subfoveal region demonstrated by clinical examination and OCT 2. Ability to maintain steady fixation for mfERG 3. Presence of abnormal dilated choroidal vasculature in ICGA 4. Symptom duration over 3 months Exclusion criteria 1. previous PDT or laser treatment history 2. evidence of Choriinal neovascularization in FAG 3. other chorioretinal disorders that can cause macular exudation such as age-related macular degeneration, pathologic myopia, angioid streaks, trauma, inflammatory diseases, retinal vasculopathies, and hereditary dystrophies follow-up Visit 1)baseline 2)1month 3)3months 4)6 months each visit: multifocal electroretinogram, visual acuity, optical coference timography should be measured.

Conditions

Timeline

Start date
2008-03-01
Primary completion
2008-10-01
Completion
2008-10-01
First posted
2008-12-05
Last updated
2009-03-12
Results posted
2008-12-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00803517. Inclusion in this directory is not an endorsement.